Birsa Nicol, Norkett Rosalind, Wauer Tobias, Mevissen Tycho E T, Wu Hsiu-Chuan, Foltynie Thomas, Bhatia Kailash, Hirst Warren D, Komander David, Plun-Favreau Helene, Kittler Josef T
From the Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London WC1E 6BT, United Kingdom.
the Medical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, United Kingdom.
J Biol Chem. 2014 May 23;289(21):14569-82. doi: 10.1074/jbc.M114.563031. Epub 2014 Mar 26.
Mitochondrial transport plays an important role in matching mitochondrial distribution to localized energy production and calcium buffering requirements. Here, we demonstrate that Miro1, an outer mitochondrial membrane (OMM) protein crucial for the regulation of mitochondrial trafficking and distribution, is a substrate of the PINK1/Parkin mitochondrial quality control system in human dopaminergic neuroblastoma cells. Moreover, Miro1 turnover on damaged mitochondria is altered in Parkinson disease (PD) patient-derived fibroblasts containing a pathogenic mutation in the PARK2 gene (encoding Parkin). By analyzing the kinetics of Miro1 ubiquitination, we further demonstrate that mitochondrial damage triggers rapid (within minutes) and persistent Lys-27-type ubiquitination of Miro1 on the OMM, dependent on PINK1 and Parkin. Proteasomal degradation of Miro1 is then seen on a slower time scale, within 2-3 h of the onset of ubiquitination. We find Miro ubiquitination in dopaminergic neuroblastoma cells is independent of Miro1 phosphorylation at Ser-156 but is dependent on the recently identified Ser-65 residue within Parkin that is phosphorylated by PINK1. Interestingly, we find that Miro1 can stabilize phospho-mutant versions of Parkin on the OMM, suggesting that Miro is also part of a Parkin receptor complex. Moreover, we demonstrate that Ser-65 in Parkin is critical for regulating Miro levels upon mitochondrial damage in rodent cortical neurons. Our results provide new insights into the ubiquitination-dependent regulation of the Miro-mediated mitochondrial transport machinery by PINK1/Parkin and also suggest that disruption of this regulation may be implicated in Parkinson disease pathogenesis.
线粒体运输在使线粒体分布与局部能量产生及钙缓冲需求相匹配方面发挥着重要作用。在此,我们证明,Miro1是线粒体外膜(OMM)蛋白,对线粒体运输和分布的调节至关重要,它是人类多巴胺能神经母细胞瘤细胞中PINK1/Parkin线粒体质量控制系统的底物。此外,在携带PARK2基因(编码Parkin)致病突变的帕金森病(PD)患者来源的成纤维细胞中,受损线粒体上Miro1的周转发生改变。通过分析Miro1泛素化的动力学,我们进一步证明,线粒体损伤会触发OMM上Miro1快速(数分钟内)且持续的赖氨酸-27型泛素化,这依赖于PINK1和Parkin。随后在泛素化开始后2 - 3小时的较慢时间尺度上可见Miro1的蛋白酶体降解。我们发现多巴胺能神经母细胞瘤细胞中的Miro泛素化不依赖于Miro1在丝氨酸-156处的磷酸化,但依赖于Parkin中最近鉴定出的被PINK1磷酸化的丝氨酸-65残基。有趣的是,我们发现Miro1可以稳定OMM上Parkin的磷酸化突变体形式,这表明Miro也是Parkin受体复合物的一部分。此外,我们证明Parkin中的丝氨酸-65对于调节啮齿动物皮质神经元线粒体损伤时的Miro水平至关重要。我们的结果为PINK1/Parkin对Miro介导的线粒体运输机制的泛素化依赖性调节提供了新见解,也表明这种调节的破坏可能与帕金森病发病机制有关。